Mon, 24 January 2022
We just reached possibly one of the largest milestones in creating pure, consistent cannabinoids in a lab. Here to tell us about it is Kevin Chen of Hyasynth Bio.
Learn more at https://hyasynthbio.com
The Zillow of Cannabis?
Let’s face it, finding real estate for your cannabis or hemp business can be challenging. There is one company that has removed all the complexity And makes it simple to browse cannabis, and hemp properties and businesses that are for sale right now. Best of all it’s free to get started, check out
[1:32] An inside look at Hyasynth Bio and its work creating biosynthesized cannabis compounds
[3:05] Hyasynth Bio’s first product, an ultra-pure CBD oil created using cultured cannabinoids
[7:44] How Hyasynth Bio is improving CBD production in terms of both speed and purity
[9:12] Why multinational companies are gravitating towards biosynthesized cannabinoids for better consistency and supply chain performance
[16:55] How biosynthesized cannabinoids are paving the way for international cannabis brands and which products Kevin believes will go global first
[21:23] How cellular agriculture is giving us better access to rare cannabinoids
[27:48] Why cellular agriculture is easier to automate and how this might influence prices in the cannabis industry
[32:21] Hyasynth Bio’s strategy to profit primarily through intellectual property licensing
[36:24] Where Hyasynth Bio currently is in the capital-raising process
Direct download: Ep_1.24.22_The_Cannabinoid_Science_Nobody_is_Talking_About.mp3
Category:general -- posted at: 9:00am EDT